The nation’s top infectious disease expert says in order to keep up with ever-evolving COVID-19, we need to be "flexible" to move with the changing virus.
"Innovative approaches are clearly needed to induce broad and durable protection against coronaviruses known and unknown," said National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci.
"Hence what we're talking about next generation. But there are two pillars of the next generation that we're all interested, concerned with and pushing for. One is a pan-coronavirus vaccine that has both breadth and durability. That's important. And next, mucosal vaccine."
Fauci's comments came on Tuesday while taking part in the White House COVID Summit, which focuses on the future of vaccines.
"One of the successes of the COVID trials was we leveraged the clinical trial network that we built over decades for HIV. We need to do that with these vaccines," said Fauci.
"Early partnership with industry and biotech in advanced development and manufacturing prior, prior to the proof of efficacy referred to as at risk. That led to unprecedented time frame for the availability of safe and effective vaccines. And finally, ending with something we all know, the cost of major investment of research pales in comparison to the cost of a pandemic."
Subscribe to our YouTube channel: [ Ссылка ]
Subscribe to our newest channel Quicktake Explained: [ Ссылка ]
Bloomberg Quicktake brings you live global news and original shows spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.
To watch complete coverage on Bloomberg Quicktake 24/7, visit [ Ссылка ], or watch on Apple TV, Roku, Samsung Smart TV, Fire TV and Android TV on the Bloomberg app.
Have a story to tell? Fill out this survey for a chance to have it featured on Bloomberg Quicktake: [ Ссылка ]
Connect with us on…
YouTube: [ Ссылка ]
Breaking News on YouTube: [ Ссылка ]
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
